Takashi Hirano

8.7k total citations
258 papers, 6.8k citations indexed

About

Takashi Hirano is a scholar working on Molecular Biology, Biomedical Engineering and Organic Chemistry. According to data from OpenAlex, Takashi Hirano has authored 258 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Molecular Biology, 34 papers in Biomedical Engineering and 30 papers in Organic Chemistry. Recurrent topics in Takashi Hirano's work include bioluminescence and chemiluminescence research (71 papers), Photoreceptor and optogenetics research (28 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Takashi Hirano is often cited by papers focused on bioluminescence and chemiluminescence research (71 papers), Photoreceptor and optogenetics research (28 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Takashi Hirano collaborates with scholars based in Japan, United States and Sweden. Takashi Hirano's co-authors include Haruki Niwa, Shôjirô Maki, Mamoru Ohashi, Satoshi Kojima, Harubumi Kato, Frederick I. Tsuji, Masahiro Tsuboi, S Inouye, Sunil C. Kaul and Takaaki Akaike and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Takashi Hirano

251 papers receiving 6.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Hirano Japan 44 3.3k 1.0k 936 883 878 258 6.8k
Katherine Luby‐Phelps United States 47 5.1k 1.6× 587 0.6× 935 1.0× 926 1.0× 553 0.6× 92 10.2k
Hans‐Joachim Galla Germany 66 6.4k 2.0× 1.2k 1.2× 2.5k 2.6× 771 0.9× 636 0.7× 275 13.7k
Thomas M. Marti Switzerland 47 3.4k 1.1× 2.0k 2.0× 366 0.4× 564 0.6× 392 0.4× 146 6.9k
Minoru Sakurai Japan 44 2.9k 0.9× 505 0.5× 723 0.8× 484 0.5× 642 0.7× 392 8.1k
Ian C. P. Smith Canada 53 4.7k 1.4× 500 0.5× 476 0.5× 1.4k 1.6× 2.4k 2.8× 259 12.1k
Richard P. Haugland United States 45 6.5k 2.0× 771 0.8× 1.8k 1.9× 365 0.4× 2.2k 2.5× 88 12.5k
Ilya Levental United States 49 7.7k 2.4× 609 0.6× 2.3k 2.4× 386 0.4× 401 0.5× 121 11.7k
Ben N. G. Giepmans Netherlands 45 6.2k 1.9× 533 0.5× 901 1.0× 216 0.2× 899 1.0× 105 9.8k
Sushmita Mukherjee United States 34 3.5k 1.1× 352 0.4× 668 0.7× 712 0.8× 259 0.3× 74 5.6k
Richard E. Pagano United States 73 11.3k 3.5× 821 0.8× 471 0.5× 669 0.8× 386 0.4× 144 15.9k

Countries citing papers authored by Takashi Hirano

Since Specialization
Citations

This map shows the geographic impact of Takashi Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Hirano more than expected).

Fields of papers citing papers by Takashi Hirano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Hirano. The network helps show where Takashi Hirano may publish in the future.

Co-authorship network of co-authors of Takashi Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Hirano. A scholar is included among the top collaborators of Takashi Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Hirano. Takashi Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Chihiro, Takuya Yagi, Kazuya Miyashita, et al.. (2023). Synthesis and anti-tumor activities in human leukemia-derived cells of polyenylpyrroles with a methyl group at the conjugated polyene terminus. Bioorganic & Medicinal Chemistry Letters. 95. 129471–129471.
2.
Furuta, Tadaomi, et al.. (2023). S-Series Coelenterazine-Driven Combinatorial Bioluminescence Imaging Systems for Mammalian Cells. International Journal of Molecular Sciences. 24(2). 1420–1420. 11 indexed citations
4.
Uekusa, Hidehiro, et al.. (2020). Isomeric difference in the crystalline-state chemiluminescence property of an adamantylideneadamantane 1,2-dioxetane with a phthalimide chromophore. Chemical Communications. 56(23). 3369–3372. 8 indexed citations
5.
Hirano, Takashi, et al.. (2016). Practical Chemistry of Long-Lasting Bubbles. 4(2). 32–44. 3 indexed citations
6.
Kiyama, Masahiro, Satoshi Iwano, Kazuto Ito, et al.. (2013). Synthesis and luminescence properties of biphenyl-type firefly luciferin analogs with a new, near-infrared light-emitting bioluminophore. Tetrahedron. 69(46). 9726–9734. 33 indexed citations
7.
Iwano, Satoshi, Rika Obata, Masahiro Kiyama, et al.. (2013). Development of simple firefly luciferin analogs emitting blue, green, red, and near-infrared biological window light. Tetrahedron. 69(19). 3847–3856. 101 indexed citations
9.
Usuda, Jitsuo, Harubumi Kato, Tetsuya Okunaka, et al.. (2006). Photodynamic Therapy (PDT) for Lung Cancers. Journal of Thoracic Oncology. 1(5). 489–493. 195 indexed citations
10.
Hirano, Takashi, et al.. (2005). Universal design for workplace. 41(1). 97–104.
11.
Koike, Naoto, Shin‐ichi Tsunoda, Sunil C. Kaul, et al.. (2004). Establishment and characterization of unique human gallbladder cancer cell lines. International Journal of Oncology. 24(5). 1189–96. 16 indexed citations
12.
Kondo, Tadashi, et al.. (2001). Novel anticancer strategy by means of DIVEMA(copolymer of divinyl ether and maleic anhydride).. Drug Delivery System. 16(2). 106–113. 3 indexed citations
14.
Okada, Shinya, Motoshige Kudo, Takashi Hirano, Akio Ishikawa, & Yoshiro Ebihara. (1999). Sarcomatoid anaplastic carcinoma of the lung with osteoclast-like giant cell reaction. A case report with special references to cytological findings.. The Journal of the Japanese Society of Clinical Cytology. 38(2). 170–176. 1 indexed citations
15.
Hirano, Takashi, Wěi Li, Lloyd Abrams, et al.. (1999). Reversible Oxygenation of a Diphenylmethyl Radical Rendered Supramolecularly Persistent. Journal of the American Chemical Society. 121(30). 7170–7171. 26 indexed citations
16.
Hirano, Takashi, Kaoru Fujioka, Bo Franzén, et al.. (1997). Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features. British Journal of Cancer. 75(7). 978–985. 27 indexed citations
17.
Franzén, Bo, Gert Auer, Ayodele Alaiya, et al.. (1996). Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors. International Journal of Cancer. 69(5). 408–414. 37 indexed citations
18.
Hirano, Takashi, Bo Franzén, Ken Okuzawa, et al.. (1995). Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma. British Journal of Cancer. 72(4). 840–848. 31 indexed citations
19.
Hirano, Takashi, Norihiko Ikeda, Ken Okuzawa, et al.. (1993). Clinical Study of Multiple Primary Lung Cancers.. Haigan. 33(6). 887–895.
20.
Yamamoto, Hirotoshi, Tatsuya Oda, Takashi Hirano, et al.. (1990). Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinyl ether-maleic acid copolymer. European Journal of Cancer and Clinical Oncology. 26(3). 253–260. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026